These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37743485)

  • 1. Clinical characteristics of breast cancer patients admitted to academic surgical wards in Tehran, Iran: an analytical cross-sectional study.
    Pourriahi R; Omranipour R; Alipour S; Hajimaghsoudi L; Mashoori N; Kenary AY; Motamedi M; Tavakol M; Mohammadzadeh M; Hessamiazar S; Shabani S; Mahmoodi F; Goodarzi MM; Eslami B
    BMC Womens Health; 2023 Sep; 23(1):511. PubMed ID: 37743485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study.
    Afsharfard A; Mozaffar M; Orang E; Tahmasbpour E
    Asian Pac J Cancer Prev; 2013; 14(11):6905-11. PubMed ID: 24377624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
    Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
    Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty years of breast cancer in Iran: downstaging without a formal screening program.
    Harirchi I; Kolahdoozan S; Karbakhsh M; Chegini N; Mohseni SM; Montazeri A; Momtahen AJ; Kashefi A; Ebrahimi M
    Ann Oncol; 2011 Jan; 22(1):93-97. PubMed ID: 20534622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women.
    Rweyemamu LP; Akan G; Adolf IC; Magorosa EP; Mosha IJ; Dharsee N; Namkinga LA; Lyantagaye SL; Nateri AS; Atalar F
    BMC Womens Health; 2021 Dec; 21(1):423. PubMed ID: 34930226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing trend of tumor size and downstaging in breast cancer in Iran: results of a 15-year study.
    Harirchi I; Karbakhsh M; Montazeri A; Ebrahimi M; Jarvandi S; Zamani N; Momtahen AJ; Kashefi A; Zafarghandi MR
    Eur J Cancer Prev; 2010 Mar; 19(2):126-30. PubMed ID: 19952761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer in Iran: results of a multi-center study.
    Harirchi I; Karbakhsh M; Kashefi A; Momtahen AJ
    Asian Pac J Cancer Prev; 2004; 5(1):24-7. PubMed ID: 15075000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer in Iran: a review of 903 case records.
    Harirchi I; Ebrahimi M; Zamani N; Jarvandi S; Montazeri A
    Public Health; 2000 Mar; 114(2):143-5. PubMed ID: 10800155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association Between Clinicopathological Features and Molecular Markers in Bahraini Women With Breast Cancer.
    AlZaman A; Ali E; Mohamad B; Islam M; AlZaman E; AlZaman Y
    Gulf J Oncolog; 2020 Jan; 1(32):19-25. PubMed ID: 32342914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronological changes and trend of breast cancer clinics and pathology among Iranian women during 22 years from the largest breast cancer registry in Iran.
    Tahmasebi S; Tajali M; Akrami M; Arasteh P; Zangouri V; Nobandegani AS; Hosseini SM; Safari A; Talei A
    World J Surg Oncol; 2019 Dec; 17(1):207. PubMed ID: 31801561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of social and clinical factors on diagnostic delay of breast cancer: A Cross-sectional Study.
    Dianatinasab M; Fararouei M; Mohammadianpanah M; Zare-Bandamiri M
    Medicine (Baltimore); 2016 Sep; 95(38):e4704. PubMed ID: 27661018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
    Brouckaert O; Rudolph A; Laenen A; Keeman R; Bolla MK; Wang Q; Soubry A; Wildiers H; Andrulis IL; Arndt V; Beckmann MW; Benitez J; Blomqvist C; Bojesen SE; Brauch H; Brennan P; Brenner H; Chenevix-Trench G; Choi JY; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Eriksson M; Fasching PA; Figueroa J; Flyger H; Giles GG; González-Neira A; Guénel P; Hall P; Hollestelle A; Hopper JL; Ito H; Jones M; Kang D; ; Knight JA; Kosma VM; Li J; Lindblom A; Lilyquist J; Lophatananon A; Mannermaa A; Manoukian S; Margolin S; Matsuo K; Muir K; Nevanlinna H; Peterlongo P; Pylkäs K; Saajrang S; Seynaeve C; Shen CY; Shu XO; Southey MC; Swerdlow A; Teo SH; Tollenaar RAEM; Truong T; Tseng CC; van den Broek AJ; van Deurzen CHM; Winqvist R; Wu AH; Yip CH; Yu JC; Zheng W; Milne RL; Pharoah PDP; Easton DF; Schmidt MK; Garcia-Closas M; Chang-Claude J; Lambrechts D; Neven P
    Breast Cancer Res; 2017 Nov; 19(1):119. PubMed ID: 29116004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study.
    Llanos AA; Chandwani S; Bandera EV; Hirshfield KM; Lin Y; Ambrosone CB; Demissie K
    Cancer Causes Control; 2015 Dec; 26(12):1737-50. PubMed ID: 26376894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of delay in diagnosis and end stage at presentation among breast cancer patients in Iran: a multi-center study.
    Foroozani E; Ghiasvand R; Mohammadianpanah M; Afrashteh S; Bastam D; Kashefi F; Shakarami S; Dianatinasab M
    Sci Rep; 2020 Dec; 10(1):21477. PubMed ID: 33293634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness levels about breast cancer risk factors, early warning signs, and screening and therapeutic approaches among Iranian adult women: a large population based study using latent class analysis.
    Tazhibi M; Feizi A
    Biomed Res Int; 2014; 2014():306352. PubMed ID: 25295257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer Subtypes in Northern Thailand and Barriers to satisfactory survival outcomes.
    Ditsatham C; Sripan P; Chaiwun B; Klunklin P; Tharavichitkul E; Chakrabandhu S; Muangwong P; Chitapanarux I
    BMC Cancer; 2022 Nov; 22(1):1147. PubMed ID: 36348356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very young breast cancer in a referral center in Tehran, Iran; review of 55 cases aged 25 or less throughout 33 years.
    Alipour S; Omranipour R; Jahanzad I; Bagheri K
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6529-32. PubMed ID: 24377562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between body mass index and immunohistochemical subtypes in breast cancer.
    Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.